← 返回

通过单细胞 RNA 测序和基因共表达网络发现与结肠腺癌中 CD8(+) T 细胞浸润和肿瘤相关纤维化相关的生物标志物

英文原题:Discovering biomarkers associated with infiltration of CD8(+) T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network.

查看英文原题

Discovering biomarkers associated with infiltration of CD8(+) T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network.

PubMed 2025/03/31(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本研究确定了三个与 CD8+T 细胞及 COAD 预后相关的关键基因,为 COAD 的诊断和治疗提供了新的预后生物标志物。

研究思路结论见上方概要

结直肠腺癌(COAD)是一种常见的恶性肿瘤,死亡率高。在肿瘤微环境中,CD8+ T细胞在人体抗肿瘤免疫反应中发挥关键作用。纤维化直接和间接影响肿瘤免疫治疗的反应。然而,与肿瘤相关纤维化和CD8+ T细胞浸润相关的调控基因的意义仍不确定。因此,迫切需要识别具有预后价值的生物标志物,并阐明CD8+ T细胞和肿瘤相关纤维化的确切作用。

我们对来自 GEO 数据库的 COAD 样本进行了单细胞转录组分析。为了评估 COAD 样本中的免疫浸润,我们使用了 CIBERSORT 和 ESTIMATE。此外,我们分析了 CD8 + T 细胞与免疫浸润之间的相关性。为了分析 COAD 表达的定量免疫细胞组成数据,我们进行了加权基因共表达网络分析并使用了去卷积算法。这些分析的数据来自 GEO 数据库。我们使用单因素 Cox 回归和 LASSO 分析来构建预后模型。通过 Kaplan-Meier 分析评估预测模型,并创建了生存预测列线图。此外,我们分析了预后模型与化疗药物敏感性之间的相关性。为了评估 hub 基因的表达,我们采用了免疫组织化学、实时 PCR 和 western blot 技术。

单细胞转录组分析表明,COAD肿瘤样本中CD8 + T细胞的比例更高。利用GEO数据库进行的WGCNA和去卷积分析进一步证实了COAD与CD8 + T细胞之间的关联。蛋白质-蛋白质相互作用网络分析揭示了三个枢纽基因:LARS2、SEZ6L2和SOX7。随后利用LASSO和单因素COX回归建立了一个包含这三个基因的预测模型。其中两个枢纽基因(LARS2和SEZ6L2)在COAD细胞系和组织中被发现上调,而SOX7则被观察到下调。该预后模型显示出与CD8 + T细胞的显著关联,表明这些基因可作为治疗COAD的潜在生物标志物和基因治疗靶点。

展开英文摘要原文

Colorectal adenocarcinoma (COAD) is a prevalent malignant tumor associated with a high mortality rate. Within the tumor microenvironment, CD8 + T cells play a pivotal role in the anti-tumor immune response within the human body. Fibrosis directly and indirectly affects the therapeutic response of tumor immunotherapy. However, the significance of regulatory genes associated with tumor-associated fibrosis and CD8 + T cell infiltration remains uncertain. Therefore, it is imperative to identify biomarkers with prognostic value and elucidate the precise role of CD8 + T cells and tumor-associated fibrosis.

We performed a single-cell transcriptome analysis of COAD samples from the GEO database. To evaluate immune infiltration in COAD samples, we utilized CIBERSORT and ESTIMATE. Furthermore, we analyzed the correlation between CD8 + T cells and immune infiltration. To analyze COAD expression's quantitative immune cell composition data, we conducted a Weighted Gene Correlation Network Analysis and utilized a deconvolution algorithm. The data for these analyses were obtained from the GEO database. We utilized univariate Cox regression and LASSO analysis to create a prognostic model. The predictive model was assessed through Kaplan-Meier analysis, and a survival prediction nomogram was created. Additionally, we analyzed the correlation between the prognostic model and chemotherapy drug sensitivity. To estimate the expression of hub genes, we employed immunohistochemistry, real-time PCR, and western blot techniques.

Single-cell transcriptome analysis has indicated a higher prevalence of CD8 + T cells in COAD tumor samples. The connection between COAD and CD8 + T cells was further confirmed by WGCNA and deconvolution analysis using the GEO database. The Protein-Protein Interaction network analysis revealed three hub genes: LARS2 , SEZ6L2 , and SOX7 . A predictive model was subsequently created using LASSO and univariate COX regression, which included these three genes. Two of these hub genes ( LARS2 and SEZ6L2 ) were found to be upregulated in COAD cell lines and tissues, while SOX7 was observed to be downregulated. The prognostic model demonstrated a significant association with CD8 + T cells, suggesting that these genes could serve as potential biomarkers and targets for gene therapy in treating COAD.

This study has identified three key genes associated with CD8 + T cells and the prognosis of COAD, providing new prognostic biomarkers for diagnosing and treating COAD.

论文信息

作者
Zhang J、Sun Z、Li G、Ding L、Wang Z、Liu M
第一作者单位
Colorectal Cancer Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.China
通讯作者单位
Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.China
期刊
Frontiers in immunology2025
原文标识
PubMed 40230854 · DOI 10.3389/fimmu.2025.1496640